Eisai Co. Ltd
Eisai Co., Ltd. engages in the research and development, manufacture, sale, and import and export of pharmaceuticals. It also offers prescription medicines. In addition, the company focuses on neurology and oncology and therapeutic areas. The company was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was incorporated in 1941 and is headqua… Read more
Market Cap & Net Worth: Eisai Co. Ltd (ESALF)
Eisai Co. Ltd (PINK:ESALF) has a market capitalization of $7.50 Billion ($7.50 Billion) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #2160 globally and #1551 in its home market, demonstrating a -11.01% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Eisai Co. Ltd's stock price $26.60 by its total outstanding shares 281891141 (281.89 Million).
Eisai Co. Ltd Market Cap History: 2016 to 2025
Eisai Co. Ltd's market capitalization history from 2016 to 2025. Data shows change from $13.13 Billion to $7.50 Billion (-6.54% CAGR).
Eisai Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Eisai Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.01x
Eisai Co. Ltd's market cap is 0.01 times its annual revenue
1.02x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.16x
Eisai Co. Ltd's market cap is 0.16 times its annual earnings
10.35x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $13.13 Billion | $547.92 Billion | $54.93 Billion | 0.02x | 0.24x |
| 2017 | $13.10 Billion | $539.10 Billion | $39.36 Billion | 0.02x | 0.33x |
| 2018 | $18.55 Billion | $600.05 Billion | $51.84 Billion | 0.03x | 0.36x |
| 2019 | $18.46 Billion | $642.83 Billion | $63.39 Billion | 0.03x | 0.29x |
| 2020 | $17.60 Billion | $695.62 Billion | $121.77 Billion | 0.03x | 0.14x |
| 2021 | $14.65 Billion | $645.94 Billion | $41.94 Billion | 0.02x | 0.35x |
| 2022 | $16.65 Billion | $756.23 Billion | $47.95 Billion | 0.02x | 0.35x |
| 2023 | $13.25 Billion | $744.40 Billion | $55.43 Billion | 0.02x | 0.24x |
| 2024 | $8.47 Billion | $741.75 Billion | $42.41 Billion | 0.01x | 0.20x |
| 2025 | $7.50 Billion | $789.40 Billion | $46.43 Billion | 0.01x | 0.16x |
Competitor Companies of ESALF by Market Capitalization
Companies near Eisai Co. Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to Eisai Co. Ltd by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Eisai Co. Ltd Historical Marketcap From 2016 to 2025
Between 2016 and today, Eisai Co. Ltd's market cap moved from $13.13 Billion to $ 7.50 Billion, with a yearly change of -6.54%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $7.50 Billion | -11.43% |
| 2024 | $8.47 Billion | -36.12% |
| 2023 | $13.25 Billion | -20.39% |
| 2022 | $16.65 Billion | +13.65% |
| 2021 | $14.65 Billion | -16.76% |
| 2020 | $17.60 Billion | -4.68% |
| 2019 | $18.46 Billion | -0.51% |
| 2018 | $18.55 Billion | +41.66% |
| 2017 | $13.10 Billion | -0.26% |
| 2016 | $13.13 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Eisai Co. Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $7.50 Billion USD |
| MoneyControl | $7.50 Billion USD |
| MarketWatch | $7.50 Billion USD |
| marketcap.company | $7.50 Billion USD |
| Reuters | $7.50 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.